Genome-wide intricacies of cancer inhibitor untangled

In a recent study, investigators administered a small-molecule inhibitor called MYCi975 to prostate cancer cells, examining the effects on gene expression throughout the human genome.

Dr. Brugarolas on unmet needs in the renal cell carcinoma treatment paradigm

Understanding the mechanisms of treatment resistance is among the areas of unmet need, says James Brugarolas, MD, PhD.

Study assesses physician workplace and psychosocial factors as predictors of medical negligence claims

“Our results also reinforce pervious recommendations that preventive efforts to improve doctors’ health and well-being need to be intensified,” the authors wrote.